Overview
CVI’s Office-Based Management of Cardiovascular Disease
CVI’s program is designed to cater to a diverse array of healthcare professionals, including physicians specializing in clinical and interventional cardiology, electrophysiology, cardiac surgery, family practice, internal medicine, emergency medicine, geriatric medicine, and primary care. Additionally, advanced practice providers such as nurse practitioners and physician assistants, along with nurses, fellows, residents, medical students, medical assistants, and all allied and home healthcare professionals involved in the care of patients with cardiovascular disease.
CVI’s Office-Based Management of Cardiovascular Disease being held:
SUNDAY OCTOBER 13, 2024
7:45AM TO 4:30PM
Marriott Conshohocken
111 Crawford Avenue
West Conshohocken, PA 19428
- 7.25 CME/CEU Credits
- 7.25 Medical Knowledge MOC Points for physicians who certify through ABIM
This year’s agenda features an outstanding diverse faculty of national thought leaders, including our Keynote Presenters, Dr Daniel Edmundowicz, Temple University and Dr. Paul Friedman, Mayo Clinic. CVI’s Cardiology Update features regional experts providing the most relevant and up-to-date information on diagnosis, management and prevention of cardiovascular diseases and addresses specific important issues in healthcare. Keynote presentations highlight SGLT-2 Inhibitors and GLP-1 Agonists in diabetes and high-risk non-diabetic patients and a review of the evolving landscapes in cardiology and artificial intelligence.
Details
The CVI Office-Based Management of Cardiovascular Disease
Sunday October 13, 2024
7:45am – 4:30pm
Marriott Conshohocken West
7.25 CME/CEU Credits
7.25 MOC Knowledge Points
Overall Learning Objectives
Participants will be able to integrate advanced knowledge and innovative strategies into clinical practice for the management of complex cardiovascular conditions:
• Describe the latest advancements in the use of SGLT-2 inhibitors and GLP-1 agonists for diabetes and high-risk non-diabetic patients.
• Explore the evolving role of artificial intelligence in cardiology and its impact on patient care.
• Develop evidence-based approaches for managing resistant hypertension.
• Recognize the interrelationship between cardiac, renal, and metabolic health, particularly in Cardiac Kidney Metabolic Syndrome.
• Identify and implement optimal treatment strategies for systolic and diastolic heart failure in real-world settings.
• Evaluate which patients with fatty liver disease require further assessment and treatment.
• Assess the appropriateness of anticoagulation therapy for patients with paroxysmal atrial fibrillation using new wearable devices.
• Enhance outcomes in hypertrophic cardiomyopathy through targeted treatment plans.
• Determine appropriate screening protocols for cardiac amyloidosis to improve early diagnosis and management.
Course Directors
Keynote Presenters
Marriott Conshohocken West, 111 Crawford Avenue, West Conshohocken, PA 19428
Marriott Conshohocken is just 15 minutes from downtown Philly and 25 miles from Philadelphia International Airport.